TELA CIK: 1561921

TELA Bio, Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
18.8
FY22:
27.0
FY23:
40.1
FY24:
46.5
FY25:
54.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−29.5
FY22:
−39.0
FY23:
−44.1
FY24:
−41.7
FY25:
−33.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−29.1
FY22:
−37.8
FY23:
−40.6
FY24:
–
FY25:
−31.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−33.3
FY22:
−44.3
FY23:
−46.7
FY24:
−38.0
FY25:
−38.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−33.3
FY22:
−44.3
FY23:
−46.7
FY24:
−37.8
FY25:
−38.8

All amounts in millions USD Data sources:SEC EDGARTwelve Data